Literature DB >> 22977230

Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A.

Marie-Ming Aynaud1, Rodolphe Suspène, Pierre-Olivier Vidalain, Bianka Mussil, Denise Guétard, Frédéric Tangy, Simon Wain-Hobson, Jean-Pierre Vartanian.   

Abstract

The human polydeoxynucleotide cytidine deaminases APOBEC3A, APOBEC3C, and APOBEC3H are capable of mutating viral DNA in the nucleus, whereas APOBEC3A alone efficiently edits nuclear DNA. Deamination is rapidly followed by excision of uracil residues and can lead to double-stranded breaks. It is not known to which protein networks these DNA mutators belong. Using a yeast two-hybrid screen, we identified the human homolog of Drosophila Tribbles 3, TRIB3, as an interactor for APOBEC3A and APOBEC3C. The interaction was confirmed by co-affinity purification. Co-transfection of APOBEC3A with a TRIB3 expression vector reduced nuclear DNA editing whereas siRNA knockdown of TRIB3 increased the levels of nuclear DNA editing, indicating that TRIB3 functioned as a repressor of A3A. It also repressed A3A-associated γH2AX positive double-stranded breaks. The interaction results in degradation of A3A in a proteasome-independent manner. TRIB3 has been linked to cancer and via its own interactors and links the A3A DNA mutators to the Rb-BRCA1-ATM network. TRIB3 emerges as an important guardian of genome integrity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22977230      PMCID: PMC3493958          DOI: 10.1074/jbc.M112.372722

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  High-throughput yeast two-hybrid assays for large-scale protein interaction mapping.

Authors:  A J Walhout; M Vidal
Journal:  Methods       Date:  2001-07       Impact factor: 3.608

3.  Hypermutation of HIV-1 DNA in the absence of the Vif protein.

Authors:  Denise Lecossier; Francine Bouchonnet; François Clavel; Allan J Hance
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

Review 4.  Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Authors:  A G Renehan; H-C Yeh; J A Johnson; S H Wild; E A M Gale; H Møller
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

Review 5.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

Authors:  J A Johnson; B Carstensen; D Witte; S L Bowker; L Lipscombe; A G Renehan
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

6.  Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium.

Authors:  Yuko Matsumoto; Hiroyuki Marusawa; Kazuo Kinoshita; Yoko Endo; Tadayuki Kou; Toshiyuki Morisawa; Takeshi Azuma; Il-Mi Okazaki; Tasuku Honjo; Tsutomu Chiba
Journal:  Nat Med       Date:  2007-04-01       Impact factor: 53.440

7.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

8.  TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.

Authors:  Keyong Du; Stephan Herzig; Rohit N Kulkarni; Marc Montminy
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

9.  DNA double-strand breaks: prior to but not sufficient in targeting hypermutation.

Authors:  Linda Bross; Masamichi Muramatsu; Kazuo Kinoshita; Tasuku Honjo; Heinz Jacobs
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

10.  Constitutive expression of AID leads to tumorigenesis.

Authors:  Il-mi Okazaki; Hiroshi Hiai; Naoki Kakazu; Shuichi Yamada; Masamichi Muramatsu; Kazuo Kinoshita; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  36 in total

1.  APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.

Authors:  Daniel J Salamango; Jordan T Becker; Jennifer L McCann; Adam Z Cheng; Özlem Demir; Rommie E Amaro; William L Brown; Nadine M Shaban; Reuben S Harris
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

2.  Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

Authors:  Allison M Land; Emily K Law; Michael A Carpenter; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

Review 3.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

4.  Clustered and genome-wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Bioessays       Date:  2014-02-26       Impact factor: 4.345

5.  Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression.

Authors:  Hironori Nishitsuji; Saneyuki Ujino; Sachiyo Yoshio; Masaya Sugiyama; Masashi Mizokami; Tatsuya Kanto; Kunitada Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

6.  APOBEC3A catabolism of electroporated plasmid DNA in mouse muscle.

Authors:  A Kostrzak; M Henry; P L Demoyen; S Wain-Hobson; J-P Vartanian
Journal:  Gene Ther       Date:  2014-10-09       Impact factor: 5.250

7.  A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.

Authors:  Shivender M D Shandilya; Markus-Frederik Bohn; Celia A Schiffer
Journal:  Virology       Date:  2014-10-29       Impact factor: 3.616

8.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

Review 9.  Molecular origins of APOBEC-associated mutations in cancer.

Authors:  Mia Petljak; John Maciejowski
Journal:  DNA Repair (Amst)       Date:  2020-07-06

10.  Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents.

Authors:  Taghreed Hirz; Charles Dumontet
Journal:  J Vis Exp       Date:  2016-03-25       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.